Who is the new Chief Executive Officer at bit.bio?

bit.bio named Przemek Obloj Chief Executive Officer, announced July 31, 2024.

Which similar companies made leadership changes around the same time?

Hewlett Packard Enterprise (July 23, 2024), PayPal (June 20, 2024), CellPoint Digital (September 12, 2024) and Innominds (August 1, 2024) also announced leadership changes within 45 days of bit.bio.

Bit.bio Appoints Przemek Obloj as Chief Financial Officer

PRIVATEJul 31, 2024

Position

Chief Executive Officer

Company

bit.bio

Przemek Obloj

CambridgeshireInformation TechnologyFinancial ServicesSoftwareScience And EngineeringPayments

Description

bit.bio announces the appointment of Przemek Obloj as Chief Financial Officer. Mr. Obloj will oversee the company’s financial strategy, including fundraising, and work closely with bit.bio’s Founder and CEO, Mark Kotter, and the executive team to support bit.bio’s continued growth and innovation.

Quick answer

Bit.bio Appoints Przemek Obloj as Chief Financial Officer (July 31, 2024). bit.bio is based in Cambridgeshire, England, United Kingdom.

Who is the new Chief Executive Officer at bit.bio?: bit.bio named Przemek Obloj Chief Executive Officer, announced July 31, 2024.
What did bit.bio announce on July 31, 2024?: bit.bio announces the appointment of Przemek Obloj as Chief Financial Officer. Mr. Obloj will oversee the company’s financial strategy, including fundraising, and work closely with bit.bio’s Founder and CEO, Mark Kotter, and the executive team to support bit.bio’s continued growth and innovation.
What does bit.bio do?: bit.bio is an award-winning human synthetic biology company - our mission: coding cells for novel cures.
Where is bit.bio based?: bit.bio is based in Cambridgeshire, England, United Kingdom.
Which similar companies made leadership changes around the same time?: Hewlett Packard Enterprise (July 23, 2024), PayPal (June 20, 2024), CellPoint Digital (September 12, 2024) and Innominds (August 1, 2024) also announced leadership changes within 45 days of bit.bio.

Source: Fundz verified event record.

Other recent leadership changes in Financial Services and Science And Engineering

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Hewlett Packard Enterprise Names Jennifer Temple as Executive Vice President and Chief Marketing & Communications Officer (July 23, 2024)
PayPal Hires Srini Venkatesan from Walmart as Chief Technology Officer (June 20, 2024)
CellPoint Digital Appoints Mark Patrick as Chief Revenue Officer (September 12, 2024)
Innominds Appoints Chinmay Pradhan as Head of Global Sales (August 1, 2024)
Gamma Technologies Appoints Mariya Akmal as Chief Financial Officer (August 1, 2024)
Hamilton Lane Announces Appointment of Eric Solfisburg and Kyle Ross to Senior Team Members for the Dedicated Insurance Solutions Team (July 29, 2024)

Who to call at bit.bio, and when

A new leader at bit.bio brings new priorities and often new vendors. The first weeks are when they listen.

An alert the day bit.bio raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at bit.bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at bit.bio. With Fundz connected, it knows.

Watch Fundz in

See plan options

Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

bit.bio

Location

Cambridgeshire, England, United Kingdom

About

bit.bio is an award-winning human synthetic biology company - our mission: coding cells for novel cures. We have developed an end-to-end platform for the creation of any human cell type. With our cutting-edge and patent-protected opti-ox precision cell programming technology, we can deterministically program human iPSCs into a chosen cell identity with unprecedented biological consistency at an industrial scale, and approximately 10 times faster than conventional methods. Our platform has the potential to unlock a new generation of medicines. Our io Cells research products provide scientists access to highly characterised, consistent, scalable human cells that enable research and drug discovery teams to accelerate their experimental timelines and reduce experimental variability, providing an important alternative to traditional workflows. We are also leveraging our platform to build a pipeline of txCells for cell therapies. To achieve our goals, we have assembled a team of pioneers in stem cell biology, cell programming, mathematical modelling and cell therapy. We are empirical, highly ambitious and driven by a shared vision. Collaboration is at the heart of bit.bio. Join us on our journey.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment bit.bio changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Book a demo Explore plans

Related People

Abbey

Likely contact at this company

••••••••@••••••••

See Abbey's verified email →

Create an account to reveal verified emails

Predictive Intelligence

Strategic

ML-powered predictions for bit.bio's next move

Learn about Strategic plan

bit.bio changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

Show me how a fractional exec uses this Or see plans and pricing →

5 screens from a live account. No signup.